Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Jul 15, 2024; 16(7): 2952-2959
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.2952
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.2952
Table 4 Comparison of serum inflammatory factors levels between the combined group and the B group, mean ± SD
| Group | n | IL-6 (pg/mL) | TNF-α (pg/mL) | IL-10 (ng/mL) | |||
| Before operation | 1 h after operation | Before operation | 1 h after operation | Before operation | 1 h after operation | ||
| A group | 80 | 44.81 ± 6.50 | 113.92 ± 13.74 | 32.04 ± 5.94 | 84.39 ± 11.73 | 29.83 ± 4.47 | 75.40 ± 9.37 |
| B group | 80 | 42.94 ± 7.17 | 128.59 ± 15.50 | 33.78 ± 7.20 | 89.46 ± 13.18 | 31.11 ± 6.00 | 83.49 ± 12.30 |
| t value | 1.728 | -6.335 | -1.667 | -2.570 | -1.530 | -4.680 | |
| P value | 0.086 | 0 | 0.097 | 0.011 | 0.128 | 0 | |
- Citation: Zhao GG, Lou C, Gao RL, Lei FX, Zhao J. Combined use of dexmedetomidine and nalbuphine in laparoscopic radical gastrectomy for gastric cancer. World J Gastrointest Oncol 2024; 16(7): 2952-2959
- URL: https://www.wjgnet.com/1948-5204/full/v16/i7/2952.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i7.2952